RESEARCH

Phase 3 Trial

A Phase 3 open- label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)

Principal Investigator
Patrick Nachman, MD

Co-Investigators
Andrew Johnson, MD
Nattawat Klomjit, MD
Sahar Koubar, MBBS
Aahd Kubbara, MD
Katie Pendleton, MD
Sami Safadi, MD

Study Coordinator
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL

Systolic Blood Pressure Intervention Trial (SPRINT)
Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data 

Principal Investigator
Paul Drawz, MD

Program Manager
Nayanjot Kaur Rai, MPH, BDS | rai00041@umn.edu

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator:
Patrick Nachman, MD

Co-Principal Investigators: 
Michelle Rheault, MD
Angie Lobo, MD

Study Coordinators: 
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

New Study Starting Soon!

New Study Starting Soon!

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative Glomerulonephritis (IC-MPGN)

Principal Investigator
Nattawat Klomjit, MD 

Co-Investigators
Patrick H. Nachman, MD

Study Coordinator:
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

Phase 2 Trial

Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)

Principal Investigator
Patrick Nachman, MD

Co-Investigator
Surabhi Thakar, MD
Katti Woerner, MD

Study Coordinators
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator: 
Patrick Nachman, MD

Co-Principal Investigators: 
Michelle Rheault, MD
Angie Lobo, MD

Study Coordinators: 
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator
Patrick Nachman, MD

Co-Principal Investigator
Angie Lobo, MD
Michelle Rheault, MD

Study Coordinators
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

A Phase 1 Study of FT819 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Principal Investigator
Parastoo Fazeli, MD

Co-Investigators
Jerry Molitor, MD, PhD
Patrick H. Nachman, MD
Marta Michalska Smith, MD

Study Coordinator:
Michelle Snyder, RN | snyde003@umn.edu

CLINICAL TRIAL

A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus

Principal Investigator
Patrick H. Nachman, MD

Co-Investigators
Parastoo Fazeli, MD
Marie Hu, MD
Nattawat Klomjit, MD 

Study Coordinator:
Victoria Quinones, RN | quino072@umn.edu

CLINICAL TRIAL

New Study Starting Soon!

About Us
The Women Kidney Program (WKP) is a novel single-center registry for women with kidney disease.

Our Goal
The overall purpose is to help advance the field of nephrology through the rigorous study of women affected by different types of kidney disease, with the main objective to better understand and care for women with kidney disease.

What is different about women with kidney disease?
Kidney disease, such as chronic kidney disease is more prevalent in women compared to men, and women face higher prevalence of sex-specific issues such as menstrual disorders, infertility, sexual dysfunction, and earlier menopause. Enhancing knowledge and awareness about women's health topics is crucial in optimizing the care and overall health of women with kidney disease. 

Studies Involve:

• Looking at medical data
• Listening to and learning from patient's stories
• Tracking participants over time
• Carrying out surveys of different measures related to women's health

These methods help the research team collect detailed information about women with kidney disease and study risk factors to improve clinical outcomes.

Current and New Patients:

Thank you for participating in the WKP research at University of Minnesota. If your contact information changes, such as you move, please call or email (wkp@umn.edu) the study coordinator with your new contact information so we can stay in touch. 

wkp@umn.edu

Study Team:

Patrick Nachman, MD
Angie S. Lobo, MD
Sahar Koubar, MBBS
Parastoo Fazeli, MD
Sabrina Burn, MD
Sisi Ma, PhD
Scott Rajala, CCRP | srajala@umn.edu
Rebecca Cote, MS, ACRP-CP 
Ben Tang

Building Interdisciplinary Research Careers in Women’s Health (BIRCWH)

• About BIRCWH
• About BIRCWH at the University of Minnesota

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL About KPMP

To provide patients with systemic inflammatory disease or vasculitis with cutting-edge, individualized, comprehensive and integrated multidisciplinary care and access to clinical trials.

Learn More

To provide patients with glomerular disease with expert, individualized care and access to clinical trials.

Learn More

About Us
The Women Kidney Program (WKP) is a novel single-center registry for women with kidney disease.

Our Goal
The overall purpose is to help advance the field of nephrology through the rigorous study of women affected by different types of kidney disease, with the main objective to better understand and care for women with kidney disease.

What is different about women with kidney disease?
Kidney disease, such as chronic kidney disease is more prevalent in women compared to men, and women face higher prevalence of sex-specific issues such as menstrual disorders, infertility, sexual dysfunction, and earlier menopause. Enhancing knowledge and awareness about women's health topics is crucial in optimizing the care and overall health of women with kidney disease. 

Studies Involve:

• Looking at medical data
• Listening to and learning from patient's stories
• Tracking participants over time
• Carrying out surveys of different measures related to women's health

These methods help the research team collect detailed information about women with kidney disease and study risk factors to improve clinical outcomes.

Current and New Patients:

Thank you for participating in the WKP research at University of Minnesota. If your contact information changes, such as you move, please call or email (wkp@umn.edu) the study coordinator with your new contact information so we can stay in touch. 

wkp@umn.edu

Study Team:

Patrick Nachman, MD
Angie S. Lobo, MD
Sahar Koubar, MBBS
Parastoo Fazeli, MD
Sabrina Burn, MD
Sisi Ma, PhD
Scott Rajala, CCRP | srajala@umn.edu
Rebecca Cote, MS, ACRP-CP 
Ben Tang

Building Interdisciplinary Research Careers in Women’s Health (BIRCWH)

• About BIRCWH
• About BIRCWH at the University of Minnesota